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Whole Body Retention in Rats of
Different l91Pt Compounds
Following Inhalation Exposure
by W. Moore, Jr.,* M. Malanchuk,* W. Crocker,*
D. Hysell,* A. Cohen,* and J. F. Stara*
The whole body retention, excretion, lung clearance, distribution, and concentration of
l9lPt in other tissues was determined in rats following a single inhalation exposure to
different chemical forms of 19iPt. The chemical forms of 19iPt used in study were 191PtCI4,
191Pt(SO4)2, '9iPtO, and 19iPt metal. Immediately after exposure most ofthe 191Pt was found
in the gastrointestinal and respiratory tract. Movement of the i9iPt through the gastroin-
testinal tract was rapid, most of the i9iPt being eliminated within 24 hr after exposure.
Lung clearance was much slower, with a clearance half-time ofabout 8 days. In addition to
the lungs, kidney and bone contained the highest concentrations of i9iPt.
Introduction
Automotive manufacturers have incorporated
into the exhaust train a noble metal oxidation
catalyst which reduces the concentrations of car-
bon monoxide (CO) and total hydrocarbons (THC)
in the exhaust. The substrate material used in the
catalyst is coated with a small amount ofplatinum
(Pt) and palladium (Pd) (approximately g Pt and
0.5 g Pd). It is not unreasonable to assume that
some of the catalytic material will be emitted into
the atmosphere, and recent studies atthis laborato-
ry have identified the presence of noble metals in
the exhaust. The chemical form of the Pt and Pd
emitted in the exhaust has not been determined.
We have given first consideration to the study of Pt
compounds because of the larger quantity of this
metal used in the catalyst (1).
The toxicity of Pt is variable, depending on its
chemical form. Investigators have described the
toxicity of the soluble Pt salts following industrial
exposure and use the term platinosis in referring to
the respiratory and/or cutaneous reactions (2-4).
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Thethreshold limit value for industrial exposure to
the soluble Pt salts is 2 ,ug/m3 as Pt (5). With the
emission of Pt in automobile exhaust, the lungs
could serve as the major portal ofentry for human
exposure. Because ofthe paucity of available infor-
mation, this study was undertaken to provide data
on whole bodyretention, tissue distribution and ex-
cretion of different chemical forms of Pt following
inhalation exposure. Major emphasis was placed
on the fate of PtO and Pt metal because it was
believed thatthese chemical formsmight be formed
preferentially in the high temperature of the ex-
haust.
Methods
Animals
Eighty-seven outbred albino rats (Charles River
CD1 strain) weighting 100-120 g were used for ex-
posure to each l9lPt compound. The animals were
maintained on a commercial diet (Purina Lab
Chow) and tap water ad libitum.
Aerosol Exposure
The animal exposure chamber was constructed
according to the design of Raabe et alt (6). The
December 1975 35design allows for the simultaneous exposure ofthe
nose only; each ofthe 87 rats breathes its own por-
tion ofthesame aerosol duringthe exposure period.
A Retec X 70/N nebulizer was operated at 15
psig pressure to produce the aerosol of aqueous
droplets. The 2 1./min (STP) of air flowing into the
nebulizer was diluted by 7 1./min of dry air at the
entrance into the drying tube. Thermo-Systems,
Inc. Model 301Z Aerosol Neutralizer served the
dual function of neutralizing the particle
electrostatic charge as well as providing the
capacity for removing the water from the aqueous
droplets by the addition of heat. A heating tape of
300-W capacity controlled by a rheostat was wrap-
ped around the Neutralizer, and the temperature
within the Neutralizer was elevated 20-25°C as an
aid in drying the particulate. The aerosol was
further diluted at the entrance to the trapezoidal
plenum so that the total air flow through the ex-
posure chamber was 80 1./min. Samples were taken
during each exposure for analysis.
191PtCl4 Particulate: The nebulizing solution
for the 191PtClI4 particulate consisted of 5.8 ml of
191, 193mpt+4 in 1M HCI assaying 7 mCi in the form
of 191 Pt and 4.2 ml ofstable PtCl4 in aqueous solu-
tion, giving a final concentration of 2.2 mg/ml.
Based on this concentration and a mean droplet
diameter of6-8,m generated bythe nebulizer, the
aerodynamic size diameter was calculated to be
nearly 1.0 ,um. The measured particulate load was
5.0 mg/m3 over the 48-min exposure period.
l9lPt(SO4)2 Particulate: The nebulizing solution
contained 5 ml of 191 193mPt(SO4)2 in 0.5M H2SO4
assaying 10 mCi in the form of l9lPt and 5 ml of
Pt(SO4)s dissolved in deionized water. There was
no evidence of precipitation of the solids in the
combined solution which contained 1.5 mg/ml. A
particulate load of 5-7 mg/m3 was generated with
an aerodynamic size diameter of nearly 1.0 tAm.
PtO2Particulate: For the PtO2 exposure, a 5.0
ml supply of 191 193Pt (SO4)2 containing 8 mCi of
191Pt in 0.3M H2S04 was mixed with 5 ml ofstable
Pt(SO4)2 in a slightly acidified aqueous solution to
provide a final 10 ml volume of approximately 1.5
mg/ml. Following passage of the aerosol through
the drying tube, the dry particles ofthe solute were
then passed through a Lindberg furnace tube
(600°C) to decompose the Pt(SO4)2 into PtO2 and
SO2. The S02 and the H2SO4 vapor formed by
volatilization ofthe original acidified solution were
largely removed by reaction with the CaCO3 in an
absorption tube, so that only the PtO2 remained in
the aerosol stream entering the exposure chamber.
The final concentration ofPtO2 was 7-8 mg/m3.
Pt Metal Particulate: For the Pt metal ex-
posure, a 10.0 ml supply of 191,193mPtCl4, assaying
6.85 mCi for l9lPt in 0.5M HCI was used. To it was
added 21.9 mg of stable PtCl4 to provide a final
concentration of 2.2 mg/ml. The PtCl4 aerosol was
decomposed in the furnace to Pt metal particles
and chlorine gas. The chlorine and the HCI vapor
volatilized from the original acidified solution were
absorbed by activated char surrounding the tubu-
lar space in the absorption tube section. Air flows
were similar to those used in the other exposures
and calculated to give a final concentration of 7-8
mg Pt metal/m3 in the exposure chamber at-
mosphere.
Radioactive Counting
Following exposure, the rats were washed to
minimize radioactive contamination of the skin
and hair. Whole body counts were then made on all
animals used in the retention studies. The animals
were counted daily for the first few days and then
every other day for the duration ofthe experiment.
The rats were housed in metabolism cages, and 24-
hr urine and fecessamples were collected for count-
ing. A 200-channel gamma spectrometer with a 5-
in. Nal (TC) crystal was used for whole body
counts. Some of the animals were sacrificed and
dissected so that the lung, gastrointestinal tract
(contents not removed), kidney, bone, and liver
burdens of l9lPt could be determined by tissue
counting. Tissue, urine, and feces samples were
counted in a refrigerated well-type scintillation
spectrometer.
Theradioactive platinum solution consisted ofa
mixture of 191,193Pt, at least 50% being l9lPt. Only
the l9lPt was counted, and all values were cor-
rected for decay (191 Pt has a half-life of 3 days).
Results
There was considerable individual variation in
the amount of radioactivity present in some of the
animals immediately after exposure. Although
differences in the total volume of air breathed by
individual animals may have been partly responsi-
ble, the major reason for the variation was at-
tributed to the rat removing its nose from the ex-
posure port and trying to turn in the cylinder.
Whole body retention curves for l9lPt as a func-
tion ofthe type ofcompound and time following in-
halation exposure are presented graphically in
Figures 1 and 2. The retention curves showed an in-
itial rapid clearance of l9lPt from the body
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Radioactive counts of24-hr urine and feces sam-
ples from rats following inhalation exposure to the
different l9lPt compounds indicated that most of
the l9lPt was eliminated in the feces, and only a
small amount was excreted inthe urine (Figs. 3 and
4). These values support the whole body data that
showed that only a small amount of l9lPt was re-
tained by the animals. Most of the l9lPt was
rapidly cleared from the lungs (probably by
mucociliary action), swallowed, and excreted via
the feces. The presence of 19lPt in the urine indi-
cated the absorption ofa small fraction ofthe 19lPt,
although it was impossible to determine the rela-
tive contributions of lung and of gastrointestinal
absorption to the total body burden.
Tissue Clearance
DAYS
FIGURE 1. Whole body retention in adult rats of l9IPt follow-
ing inhalation exposure to 191Pt C14 and l9lPt(SO4)2.
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FIGURE 2. Whole body retention in adult rats of '1'Pt follow-
ing inhalation exposure to 191PtO2 and l9lPt metal.
followed by a slower clearance phase during the re-
mainder ofthe post-exposure period. No significant'
difference in whole body retention of l9lPt was ap-
parent following inhalation exposure to the
different chemical forms; however, clearance of
191PtCl4 seemed to be more rapid.
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FIGURE 3. Excretion of l9lPt following inhalation exposure to
PtCl4 and 191Pt(SO4)2.
could be determined by tissue counting. The
clearance curves for different organs following ex-
posure to 19lPt metal and 19lPtO are presented in
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FIGURE 5. Clearance of 19'Pt from different organs following
inhalation exposure to l9lPt metal.
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FIGURE 4. Excretion of l9lPt following inhalation exposure to
191PtO and 19kPt metal.
Figures 5 and 6. Immediately after exposure most
of the radioactivity was found in the gastroin-
testinal and respiratory tract. Movement of the
l9lPt through the gastrointestinal tract was rapid,
most of the l9lPt being eliminated within 24 hr
after exposure. Removal of the deposited l9lPt
from the lungs was much slower.
The initial lung burdens for 19'Pt metal had a
coefficient ofvariation ofabout 34% and a range of
about a factor of 2.6. The initial lung burdens for
l9lPt metal represented about 14% of the initial
body burdens. For the l9lPtO exposure, the initial
lung burdens had a coefficient ofvariation of 30%
and a range ofabout 3. The initial lung burdens for
l9lPtO were about 16% ofthe initial body burdens.
This spread was consistent with the reported
variability in rodent inhalation exposures (6, 7).
The percentage of the initial lung burden retained
for the duration of the study is given in Table 1.
The data indicate that Pt(S04)2 may be more
rapidly mobilized from the lung.
The clearance of 19lPt from the lungs may be
divided into an initial rapid decrease of activity
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FIGURE 6. Clearance of 191Pt from different organs following
inhalation exposure to l9lPtO.
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38Table 1. Percentage of initial lung burden retained with
time in the lungs.
Portion of Pt burden retained, %
Time, days Pt metal PtO Pt(SO4)2
1 63.0 57.2 73.7
2 49.5 60.9 43.4
4 41.3 49.0 20.4
8 42.9 28.6
16 28.0 17.9 4.4
over the first 24 hr followed by a slower clearance
phase during the rest of the post-exposure period.
For the slow phase, the clearance half-time was
about 8 days.
The distribution and concentration of 191Pt in
other tissues following exposure to 191Pt metal are
given in Table 2. In addition to the lung and
trachea, the kidney and bone contained the highest
amount of 191Pt. The relative large amount of 191Pt
found in the kidney and bone suggests that these
Table 2. Radioactive i9iPt in selected tissues following in-
halation exposure to Pt metal.
Mean counts per gram
Tissues 1 day 2 days 4 days 8 days
after ex- after ex- after ex- after ex-
posure posure posure posure
Blood 61 43 30 12
Trachea 1909 2510 738 343
Lung 45,462 28,784 28,280 23,543
Liver 52 46 37 17
Kidney 750 1002 906 823
Bone 281 258 231 156
Brain 5 3 1 0
Muscle 22 10 28 0
Spleen 39 73 23 5
Heart 37 58 23 5
organs accumulate this element. The low radioac-
tive count for the brain suggested the possibility
that the circulating 191Pt may be complexed to
large molecules that do not cross the blood brain
barrier.
Discussion
Clinical platinosis has been found in individuals
working with the complex platinum salts (sodium,
potassium, or ammonium tetrachlorplatinate or
hexachloroplatinate) encountered in refining and
analysis of the metal. The majority of individuals
working in atmospheres containing these salts
develop respiratory symptoms or skin lesions or
both only after occupational exposure periods of
months or years. Only one case of dermatitis has
been reported from metallic platinum (8). Evidence
indicates that the clinical syndrome ofplatinosis in
man is the result of hypersensitivity to platinum
salts. The platinum salts apparently act as a
hapten and combine with an endogenous protein to
form an allergenic hapten-protein complex (9).
The results from this study indicate that all the
chemical forms tested [PtCl4, Pt(SO4)2, PtO, Pt]
were absorbed from the lungs and entered various
body pools. Also a comparison of absorption
following inhalation and oral exposure indicate
that the respiratory route is a more effective portal
ofentry for Pt (10). It is reasonable to assume that
these forms of Pt are also absorbed following in-
halation exposure in humans. The question re-
mains why metallic and other simple salts of Pt
have not been reported as being effective agents in
producing platinosis. Platinosis is a rare disease
outside platinum refineries; however, if platinum
increases as an atmospheric pollutant, one might
anticipate concomitant increase in allergic reac-
tions.
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